Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 224

Similar articles for PubMed (Select 15140415)

1.

Airway mucus hypersecretion in asthma: an undervalued pathology?

Rogers DF.

Curr Opin Pharmacol. 2004 Jun;4(3):241-50. Review.

PMID:
15140415
2.

Mucus and MUC in asthma.

Morcillo EJ, Cortijo J.

Curr Opin Pulm Med. 2006 Jan;12(1):1-6. Review.

PMID:
16357571
3.

New pharmacotherapy for airway mucus hypersecretion in asthma and COPD: targeting intracellular signaling pathways.

Lai H, Rogers DF.

J Aerosol Med Pulm Drug Deliv. 2010 Aug;23(4):219-31. doi: 10.1089/jamp.2009.0802. Review.

PMID:
20695774
4.

Mucus pathophysiology in COPD: differences to asthma, and pharmacotherapy.

Rogers DF.

Monaldi Arch Chest Dis. 2000 Aug;55(4):324-32. Review.

PMID:
11057087
5.

Pulmonary mucus: Pediatric perspective.

Rogers DF.

Pediatr Pulmonol. 2003 Sep;36(3):178-88. Review.

PMID:
12910578
6.

Treatment of airway mucus hypersecretion.

Rogers DF, Barnes PJ.

Ann Med. 2006;38(2):116-25. Review.

PMID:
16581697
7.
8.

Mucus hypersecretion in asthma: intracellular signalling pathways as targets for pharmacotherapy.

Lai HY, Rogers DF.

Curr Opin Allergy Clin Immunol. 2010 Feb;10(1):67-76. doi: 10.1097/ACI.0b013e328334643a. Review.

PMID:
19907312
9.

Mucin-producing elements and inflammatory cells.

Jeffery P, Zhu J.

Novartis Found Symp. 2002;248:51-68; discussion 68-75, 277-82. Review.

PMID:
12568488
10.

Mucoactive agents for airway mucus hypersecretory diseases.

Rogers DF.

Respir Care. 2007 Sep;52(9):1176-93; discussion 1193-7. Review.

11.

Novel approaches for inhibition of mucus hypersecretion in asthma.

Agrawal A, Mabalirajan U, Ram A, Ghosh B.

Recent Pat Inflamm Allergy Drug Discov. 2007 Nov;1(3):188-92. Review.

PMID:
19075982
12.

Physiology of airway mucus secretion and pathophysiology of hypersecretion.

Rogers DF.

Respir Care. 2007 Sep;52(9):1134-46; discussion 1146-9. Review.

13.

Current and future therapies for airway mucus hypersecretion.

Barnes PJ.

Novartis Found Symp. 2002;248:237-49; discussion 249-53, 277-82. Review.

PMID:
12568498
14.

Mucus hypersecretion in chronic obstructive pulmonary disease.

Rogers DF.

Novartis Found Symp. 2001;234:65-77; discussion 77-83. Review.

PMID:
11199104
15.

Mucoactive drugs for asthma and COPD: any place in therapy?

Rogers DF.

Expert Opin Investig Drugs. 2002 Jan;11(1):15-35. Review.

PMID:
11772318
16.

Goblet cell and mucin gene abnormalities in asthma.

Fahy JV.

Chest. 2002 Dec;122(6 Suppl):320S-326S. Review.

PMID:
12475809
17.

Structural changes in the airways in asthma: observations and consequences.

Bai TR, Knight DA.

Clin Sci (Lond). 2005 Jun;108(6):463-77. Review.

PMID:
15896192
18.

Epithelial mucus-hypersecretion and respiratory disease.

Danahay H, Jackson AD.

Curr Drug Targets Inflamm Allergy. 2005 Dec;4(6):651-64. Review.

PMID:
17305521
19.
20.

The pharmacologic approach to airway clearance: mucoactive agents.

Rubin BK.

Respir Care. 2002 Jul;47(7):818-22. Review.

PMID:
12088552
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk